Stella buys Field Trip ketamine assets | Crain's Chicago Business
Walgreens earnings disappoint, Augmedic's big venture-capital haul and more in today's Health Pulse.
Source: chicagobusiness.com
Stay updated with breaking news from Amardeep Manhas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Walgreens earnings disappoint, Augmedic's big venture-capital haul and more in today's Health Pulse.
Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.